{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:56:07Z","timestamp":1780624567562,"version":"3.54.1"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":3186,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.seizure.2004.04.010","type":"journal-article","created":{"date-parts":[[2004,6,18]],"date-time":"2004-06-18T13:35:57Z","timestamp":1087565757000},"page":"S66-S70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"S1","title":["Zonisamide clinical trials: European experience"],"prefix":"10.1016","volume":"13","author":[{"given":"Martin J.","family":"Brodie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2004.04.010_BIB1","unstructured":"Seino M, Naruto S, Ito T, Miyazaki H. Other antiepileptic drugs. ZNS. In: Levy R, Mattson R, Meldrum B, editors. Antiepileptic drugs. New York: Raven Press; 1995. p. 1011\u201323."},{"key":"10.1016\/j.seizure.2004.04.010_BIB2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0920-1211(93)90011-U","article-title":"Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial","volume":"15","author":"Schmidt","year":"1993","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2004.04.010_BIB3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0920-1211(93)90021-X","article-title":"Efficacy and safety of zonisamide: results of a multicenter study","volume":"14","author":"Leppik","year":"1993","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2004.04.010_BIB4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1528-1157.1985.tb05407.x","article-title":"Pilot study of zonisamide (1,2-benzisoxazole-3-methanesulfonamide) in patients with refractory partial seizures","volume":"26","author":"Sackellares","year":"1985","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2004.04.010_BIB5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00007691-198609000-00010","article-title":"Comparative pharmacokinetics of zonisamide (CI-912) in epileptic patients on carbamazepine or phenytoin monotherapy","volume":"8","author":"Ojemann","year":"1986","journal-title":"Ther Drug Monit"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131104000895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131104000895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:30:25Z","timestamp":1761010225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131104000895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":5,"alternative-id":["S1059131104000895"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2004.04.010","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zonisamide clinical trials: European experience","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2004.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}